Results 111 to 120 of about 2,314,750 (241)

Evaluation of the diagnostic value of different serum biomarkers in girls with central precocious puberty

Egyptian Pediatric Association Gazette
Background Alarming trends show an increase in referrals of girls with suspected early puberty. However, variations in defining precocious puberty exist.
Yasmine Abdelmeguid, Omneya Abdelkarem, Shaymaa Raafat   +2 more
doaj   +1 more source

THE ROLE OF ANTI-MULLERIAN HORMONE IN THE PATOGENESIS OF ENDOMETRIOSIS

V.F.Snegirev Archives of Obstetrics and Gynecology, 2019
Anti-Müllerian hormone is one of the most significant factors regulating woman’s reproductive function, which inhibits endogenous production of estrogens, induces cell cycle arrest, apoptosis and autophagy in human endometrial stromal cells. Disturbance of Anti-Müllerian hormone expression could be an important link to pathogenesis of endometriosis.
N. B Paramonova, Tatyana A. Semeryuk
openaire   +1 more source

Biochemical profiling and symptomatology of androgen deficiency in males with cluster headache: A prospective case–control study

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives/Background Cluster headache (CH) has historically been considered a male‐dominated disorder, suggesting a role for androgens in its pathophysiology. We aimed to evaluate hormone profiles and symptoms of androgen deficiency in CH.
Willemijn C. Naber, Roemer B. Brandt, Mariël Leon Morales‐Grooters, Ronald van der Wal, Sjoerd A. A. van den Berg, Jelle J. Goeman, Antoinette Maassen van den Brink, Rolf Fronczek   +7 more
wiley   +1 more source

Anti-mullerian hormone as a marker of ovarian reserve

, 2005
ObjectiveTo analyse the usefulness of plasma anti-mullerian hormone (AMH) measurement as a tool for assessing ovarian reserve in a general infertility population.Materials and methodsPlasma AMH levels were analysed in 238 women aged 18-46 years during ...
Lekamge, D., Gilmore, T., Tremellen, K., Kolo, M.   +3 more
core   +1 more source

Frailty in Adults With Down Syndrome: Cognitive, Functional and Biomarker Associations

Journal of Intellectual Disability Research, EarlyView.
ABSTRACT Background Down syndrome (DS) entails widespread age‐related functional decline affecting multiple organ systems, including genetically determined early‐onset Alzheimer disease (DSAD), resulting in an increased vulnerability to frailty early in life.
Georg Nübling, Lena Marth, Katja Sandkühler, Anna Stockbauer, Elisabeth Wlasich, Alexander Jäck, Olivia Wagemann, Julia Kustermann, Steffen Halbgebauer, Hayrettin Tumani, Günter Höglinger, Johannes Levin   +11 more
wiley   +1 more source

Serum anti-mullerian hormone levels in women with secondary amenorrhea

, 2006
Anti-mullerian hormone (AMH) appears to regulate follicular growth. The aim of this study was to investigate AMH serum levels in patients affected by secondary amenorrhea.
LA MARCA , Antonio, Pati M, Artenisio AC, Orvieto R, VOLPE, Annibale, Stabile G   +5 more
core   +1 more source

Serum Anti-Müllerian Hormone Levels in Patients with Epithelial Ovarian Cancer

International Journal of Endocrinology, 2013
Objectives. The aim of our study was to examine serum anti-Müllerian hormone (AMH) concentration in ovarian cancer patients in relation to clinicopathological features, such as a pathological subtype of the tumor, (FIGO) stage, grading, and overall 5 ...
Pawel Walentowicz, Pawel Sadlecki, Magdalena Krintus, Grazyna Sypniewska, Aneta Mankowska-Cyl, Marek Grabiec, Malgorzata Walentowicz-Sadlecka   +6 more
doaj   +1 more source

Predicting ovarian aging: anti-Mullerian hormone [PDF]

Human Reproduction, 2012
Andrew S, Blazar, Sandra A, Carson, Jared C, Robins   +2 more
openaire   +2 more sources

Recent advances in polyendocrine metabolic ovarian syndrome, formerly polycystic ovary syndrome, with emphasis on endocrine and metabolic dysfunction and cardiovascular risk

Journal of Internal Medicine, EarlyView.
Abstract Polyendocrine metabolic ovarian syndrome (PMOS), previously known as polycystic ovary syndrome, affects 10%–13% of women of reproductive age and remains underdiagnosed despite its substantial health burden. The introduction of the new PMOS nomenclature in 2026 reflects a fundamental shift in understanding the condition as a lifelong endocrine ...
Maria Forslund, Johanna Melin, Anju E. Joham, Terhi T. Piltonen, D. Aled Rees, Helena J. Teede   +5 more
wiley   +1 more source

Incretin‐Based Medications in Women and Reproduction: A Systematic Scoping Review and Consensus Guidelines for Clinical Practice

Obesity Reviews, EarlyView.
ABSTRACT Introduction Pregnancy concurrent with incretin‐based medications is contraindicated due to unknown risk of teratogenicity, as is breastfeeding. The aim of this systematic scoping review was to investigate potential risks and benefits of incretin‐based medications in relation to preconception, pregnancy, and postnatal health, and to propose ...
Kate Maslin, Jill Shawe, Sinead Blowers, Michael Ceulemans, Kathryn Hart, Sam Schoenmakers, Amihai Rottenstreich, Heather Hopper, Mojca Jensterle, Angela C. Flynn, Sarah Siegelaar, Annick Bogaerts, Isy Douek, Nicola Heslehurst, Dries Ceulemans, Tricia Tan, Johnathan Pinkney, Martin Whyte, Shahrad Taheri, Roland Devlieger   +19 more
wiley   +1 more source